189 related articles for article (PubMed ID: 32016671)
21. Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer.
Hirahara N; Matsubara T; Kaji S; Hayashi H; Sasaki Y; Kawakami K; Hyakudomi R; Yamamoto T; Tajima Y
Oncotarget; 2023 Jan; 14():71-82. PubMed ID: 36719281
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy.
Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T
Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of the advanced lung cancer inflammation index in patients with gastric cancer after radical gastrectomy: a propensity-score matching cohort study and meta-analysis.
Pang H; Dai L; Chen L; Chen X; Chen Z; Zhang S; Sun H
BMC Cancer; 2024 May; 24(1):583. PubMed ID: 38741082
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer.
Chen Y; Wang W; Zhang X; Yu X; Xi K; Wen Y; Wang G; Feng X; Zhang L
Cancer Manag Res; 2018; 10():5411-5422. PubMed ID: 30519089
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of preoperative inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma.
Hirahara N; Matsubara T; Kawahara D; Nakada S; Ishibashi S; Tajima Y
Eur J Surg Oncol; 2017 Feb; 43(2):493-501. PubMed ID: 28034501
[TBL] [Abstract][Full Text] [Related]
27. Comparative Analysis of Preoperative Ratio Based Markers in Predicting Postoperative Infectious Complications After Gastrectomy.
Gülmez S; Senger A; Uzun O; Ozduman O; Ofluoglu C; Subasi İ; Sen B; Pence M; Duman U; Polat E
Pol Przegl Chir; 2022 Aug; 95(4):1-5. PubMed ID: 36807098
[TBL] [Abstract][Full Text] [Related]
28. Preoperative lymphocyte-to-monocyte ratio is the most predictive inflammatory response marker of survival in gastric cancer.
Okuno K; Tokunaga M; Yamashita Y; Umebayashi Y; Saito T; Fukuyo R; Sato Y; Saito K; Fujiwara N; Hoshino A; Kawada K; Matsuyama T; Kinugasa Y
Langenbecks Arch Surg; 2021 Nov; 406(7):2287-2294. PubMed ID: 34165594
[TBL] [Abstract][Full Text] [Related]
29. A Longitudinal Investigation of Inflammatory Markers in Colorectal Cancer Patients Perioperatively Demonstrates Benefit in Serial Remeasurement.
Chan JCY; Diakos CI; Chan DLH; Engel A; Pavlakis N; Gill A; Clarke SJ
Ann Surg; 2018 Jun; 267(6):1119-1125. PubMed ID: 28394869
[TBL] [Abstract][Full Text] [Related]
30. [Assessment value of preoperative platelet-lymphocyte ratio in the prognosis of patients with gastric mixed adenoneuroendocrine carcinoma].
Cao L; Lu J; Lin J; Zheng C; Li P; Xie J; Wang J; Chen Q; Lin M; Tu R; Huang C
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1252-1257. PubMed ID: 27928795
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy.
Hirahara N; Matsubara T; Mizota Y; Ishibashi S; Tajima Y
BMC Surg; 2016 Sep; 16(1):66. PubMed ID: 27650456
[TBL] [Abstract][Full Text] [Related]
32. Preoperative Neutrophil to Lymphocyte Ratio and Lymphocyte to Monocyte Ratio are Prognostic Factors in Gastric Cancers Undergoing Surgery.
Lieto E; Galizia G; Auricchio A; Cardella F; Mabilia A; Basile N; Del Sorbo G; Castellano P; Romano C; Orditura M; Napolitano V
J Gastrointest Surg; 2017 Nov; 21(11):1764-1774. PubMed ID: 28752404
[TBL] [Abstract][Full Text] [Related]
33. Clinical and prognostic significance of preoperative lymphocyte-monocyte ratio, neutrophil-lymphocyte ratio and neutrophil-monocyte ratio on esophageal squamous cell carcinoma patients.
Shang QX; Yang YS; Hu WP; Yuan Y; He Y; Zhao JY; Ji AF; Chen LQ
Transl Cancer Res; 2020 Jun; 9(6):3903-3914. PubMed ID: 35117757
[TBL] [Abstract][Full Text] [Related]
34. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1-2 rectal cancer.
Xia LJ; Li W; Zhai JC; Yan CW; Chen JB; Yang H
BMC Cancer; 2020 Mar; 20(1):208. PubMed ID: 32164623
[TBL] [Abstract][Full Text] [Related]
35. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
[TBL] [Abstract][Full Text] [Related]
36. Prognostic importance of dynamic changes in systemic inflammatory markers for patients with gastric cancer.
Lin JX; Huang YQ; Wang ZK; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Li P; Huang CM; Zheng CH
J Surg Oncol; 2021 Sep; 124(3):282-292. PubMed ID: 33914909
[TBL] [Abstract][Full Text] [Related]
37. The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Jiang C; Zhang S; Qiao K; Xiu Y; Yu X; Huang Y
Clin Breast Cancer; 2022 Jul; 22(5):424-438. PubMed ID: 35428593
[TBL] [Abstract][Full Text] [Related]
38. Clinical Impact of the Lymphocyte-to-Monocyte Ratio in Patients With Gastric Cancer who Received Curative Treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Tamagawa A; Cho H; Numata M; Morita J; Tanabe M; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Apr; 44(4):1567-1574. PubMed ID: 38537996
[TBL] [Abstract][Full Text] [Related]
39. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.
Kubota K; Ito R; Narita N; Tanaka Y; Furudate K; Akiyama N; Chih CH; Komatsu S; Kobayashi W
BMC Cancer; 2022 Apr; 22(1):368. PubMed ID: 35392843
[TBL] [Abstract][Full Text] [Related]
40. [Effect of preoperative monocyte-lymphocyte ratio on prognosis of patients with resectable esophagogastric junction cancer].
Zhou WJ; Wu J; Li XD; Wang Q; Ni XF; Jiang JT; Ji M; Wu CP
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):178-183. PubMed ID: 28316215
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
